KALA KALA BIO, Inc.
Healthcare$2.43-6.54%ClosedMarket Cap: $53.3M
As of 2026-05-25
Analyst Consensus
Consensus
Hold
Target (Consensus)
$18.25
Target (Median)
$18.25
Target Range
$1.50 - $35.00
Upside from current price: 651.0%
Rating Distribution
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-09-29 | HC Wainwright & Co. | downgrade | Neutral | Buy |
| 2025-09-17 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2025-09-11 | Oppenheimer | maintain | Outperform | Outperform |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Thu Dec 31 | $-26.50 | $25.0M | 1 |
| Fri Dec 31 | $-20.00 | $26.1M | 1 |
| Sun Dec 31 | $-9.00 | $134.2M | 1 |
| Mon Dec 31 | $-8.50 | $229.3M | 1 |